- Bioidentical hormones are synthetic hormones that are chemically identical to those the human body produces. They are primarily used in hormone replacement therapies (HRT) to treat symptoms associated with menopause, andropause, thyroid disorders, and other hormonal imbalances
- The demand for bioidentical hormones is significantly driven by the increasing aging population, rising awareness of hormone-related health issues, and a growing preference for personalized medicine and natural treatment options
- North America is expected to dominate the bioidentical hormones market, accounting for approximately 52.38% of the global market share because of widespread adoption of cutting-edge medical technologies
- Asia-Pacific is expected to be the fastest growing region in the bioidentical hormones market, with a percentage of 20.3% due to increasing awareness regarding health
- Estrogen segment segment is expected to dominate the market with a market share of 41.75%, due to the rising prevalence of menopause and increasing demand for estrogen-based therapies
